According to published research, miR-491-3p directly targeted insulin-like growth factor 1 receptor (IGF1R) and MKK7, a mitogen-activated protein kinase, to suppress tumor metastasis (Kumar et al. 2017; Sakai et al. 2014). Here, MAP2K7 is linked to neoplasm.